Jun 29, 2021· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2020-D-0770-0008
Comments from the Consumer Healthcare Products Association (CHPA)
FDANonrulemakingFDA-2020-D-0770
Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability
RIN
—
Last modified
Jun 29, 2021
Comment window
closed 1870d ago
Consumer Healthcare Products Association filings
1
Activity
Consumer Healthcare Products Association filed 1 comment on this docket between Jun 29, 2021 and Jun 29, 2021. 0 other organizations filed here. The comment window closed 1870d ago.
What Consumer Healthcare Products Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- Consumer Healthcare Products AssociationTHIS ORG1 filing · confidence 97%